We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Ezetimibe/Atorvastatin

Australian Public Assessment Report

AusPAR

AusPAR: Ezetimibe/Atorvastatin [PDF, 612.34 KB]

AusPAR: Ezetimibe/Atorvastatin [DOCX, 685.25 KB]

Attachment: Product Information: Ezetimibe/Atorvastatin [PDF, 372.73 KB]

Attachment: Product Information: Ezetimibe/Atorvastatin [DOC, 399.5 KB]

Attachment: Extract from Clinical Evaluation Report for Ezetimibe/Atorvastatin [PDF, 1.3 MB]

Attachment: Extract from Clinical Evaluation Report for Ezetimibe/Atorvastatin [DOCX, 3.52 MB]

Device/Product Name

Atozet / Zeteze

Active ingredients

Ezetimibe / Atorvastatin

AusPAR Date

11 July 2017

Published

15 August 2017

Submission Number

PM-2015-04334-1-3

Submission Type

Extension of indications

Decision

Approved

Product types

Prescription medicines